Senseonics Holdings, Inc. (SENS)
NASDAQ
Healthcare
Medical - Devices
$5.15
▼ -0.58%
Market Cap
$215.2M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.99
52-Wk Range
4.79-11.58
CEO
Timothy T. Goodnow
Country
US
Currency
USD
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-…
Open full interactive analysis & DCF →